Senseonics Partners With Rimidi To Develop Innovative Diabetes Solution

By Author: otis
Total Articles: 386
Comment this article

Senseonics Holdings, Inc. (NYSE American: SENS) recently announced a strategic collaboration with Rimidi to develop the Eversense Remote Patient Monitoring (RPM) Program, with a focus on enhancing diabetes care through innovative technological solutions. Rimidi, renowned for its clinical management platform, seeks to improve patient experiences and streamline clinical workflows for chronic disease management, particularly in diabetes care.

The partnership will involve integrating Eversense glucose data into Rimidi's extensive clinical management platform, which is utilized by health systems, capitated health plans, and physician practices. This integration is in line with Medicare's reimbursable remote patient monitoring telehealth programs and seamlessly integrates with existing Electronic Health Record (EHR) systems. The goal of this collaboration is to support quality improvement efforts, enhance workflow efficiency, boost patient engagement, and offer clinical decision support.

The Eversense CGM + RPM solution, in collaboration with Rimidi, aims to securely transmit patient glucose data to commonly used EHR ...
... systems, allowing healthcare providers direct access to this information. This increased visibility into glucose trends, frequency of high or low events, and time-in-range statistics will enable providers to proactively engage with patients and offer guidance on lifestyle and therapy optimization, ultimately leading to improved diabetes management, reduced healthcare expenses, and enhanced clinical outcomes.

Tim Goodnow, PhD, President and Chief Executive Officer of Senseonics, emphasized that the Eversense RPM Program is a key component of their strategy to merge long-term implantable CGM technology with advanced analytics and personalized health services to create a comprehensive diabetes solution. This program aims to equip providers with valuable data to enhance care in between office visits, where a significant portion of diabetes management takes place. The Eversense CGM+RPM solution, in partnership with Rimidi's platform, seeks to set Eversense apart from other CGM manufacturers by offering a holistic solution.

Read More - https://www.techdogs.com/tech-news/business-wire/senseonics-partners-with-rimidi-to-develop-innovative-diabetes-solution